Diabetic Neuropathy, Painful Completed Phase 2 Trials for Dasolampanel etibutil (DB12049)

IndicationStatusPhase
DBCOND0030279 (Diabetic Neuropathy, Painful)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00785577A Study for Treatment of Pain in Patients With Diabetic Neuropathy.Treatment